高级搜索
恶性肿瘤并发深静脉血栓形成33例诊治分析[J]. 肿瘤防治研究, 2012, 39(05): 570-572. DOI: 10.3971/j.issn.1000-8578.2012.05.019
引用本文: 恶性肿瘤并发深静脉血栓形成33例诊治分析[J]. 肿瘤防治研究, 2012, 39(05): 570-572. DOI: 10.3971/j.issn.1000-8578.2012.05.019
Clinical Study on 33 Cases of Malignant Tumor Complicated with Venous Thrombotic Embolism[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 570-572. DOI: 10.3971/j.issn.1000-8578.2012.05.019
Citation: Clinical Study on 33 Cases of Malignant Tumor Complicated with Venous Thrombotic Embolism[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 570-572. DOI: 10.3971/j.issn.1000-8578.2012.05.019

恶性肿瘤并发深静脉血栓形成33例诊治分析

Clinical Study on 33 Cases of Malignant Tumor Complicated with Venous Thrombotic Embolism

  • 摘要: 目的 探讨恶性肿瘤患者合并静脉血栓形成(VTE)的影响因素,治疗及VTE对生存的影响。方法 回顾性分析本科近年收治的33例合并VTE的恶性肿瘤患者临床资料,对栓塞部位,血小板,D-二聚体及纤维蛋白原水平及生存资料进行分析。结果 1例肺栓塞患者4小时内死亡。其余32例患者中,痊愈11例,好转8例,无效14例。恶性肿瘤发生VTE时血浆D-二聚体及纤维蛋白原水平明显高于正常值,且D-二聚体高水平患者的中位生存期(80天)远低于低水平的患者(420 天),两者比较差异有统计学意义(P=0.026)。结论 恶性肿瘤患者并发VTE后严重影响生存,治疗主要采用抗凝,祛聚集等。D-二聚体以及纤维蛋白原水平对于VTE诊断及预后有临床价值。

     

    Abstract: Objective To assess the influencing factors,treatment and prognosis of malignant tumor patients with venous thomboembolic events(VIE). Methods The clinical data, including the site of thrombosis,platelet,D-dimer and fibrinogen level,of 33 patients with malignant tumor and VTE were retrospectively analyzed. Results One case complicated with pulmonary embolism(PTE) died within 4 h.Among the other 32 cases with deep venous thrombosis(DVT),11 cases obtained complete response,8 partial response,and 14 progress proceed.D-dimer and fibrinogen increased when VTE occurred.The median survival time of patients with high level D-dimer was 80 d which was lower than those patients with low levels(420 d).They showed significant difference(P=0.026). Conclusion The main treatments of anti-VTE are anticoagulation and anti-assembly.D-dimer,Fibrinogen in the diagnosis and prognosis determination of the patients with VTE are important prognostic factors.

     

/

返回文章
返回